Topic 10: VAD Flashcards

1
Q

Roller pumps aren’t good VADS

Limitations?

A

Tethering, Blood trauma, Adjust pump speeds due to changes in heart pressures.

1963–Spencer, et al. Reported using a roller pump to support a patient to recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

1st successful clinical application of a true

VAD - who? when?

A

DeBakey, 1966

Pneumatically driven diaphragm pump
Paracorporeal
LA to Axillary Artery
37yo patient who could not be weaned from
CPB s/p AVR/MVR
Supported for 10 days
Weaned and Discharged
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

1st used a Total Artificial Heart (TAH) to temporarily support a patient to transplant

A

Cooley, 1969

47yo man with failure to wean from CPB s/p LV Aneurysm repair
TAH had only been tested for up to 12 hours in an animal model
Implanted the “Liotta Heart” which was a pneumatic device
Supported the patient for 64 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

University of Utah investigators were the first in the world to implant a permanent what? when?

A

TAH on 12/2/1982

Jarvik 7 TAH performed by Dr. William DeVries
Implanted into Dr. Barney Clark, 61yo dentist with end stage idiopathic dilated cardiomyopathy
Died of complications from aspiration pneumonia, Renal failure, colitis with septicemia.
Was supported for 112 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

1st planned TAH implant as a Bridge to

Transplant (BTT)

A

1985–Copeland at the University of Arizona

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Syncardia, Cardiowest–Tucson, AZ

A

Drs. Olsen and Copeland revived the first TAH model
Modified and renamed–Cardiowest C70
Received FDA Approval as a BTT in 2004

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Transplantation provided a stimulus for the development of what?

A

VADs for support until transplant

30% of patients died on the list
Became an incentive to develop devices that could be used for patients with acute cardiac decompensation while awaiting transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

9/1984–Stanford University

Oyer and Colleagues –Implanted the Novacor LVAD - which is what?

A

1st successful transplant s/p BTT with LVAD

Followed by Hill and colleagues who implanted a Pearce-Donachey pneumatic LVAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

1992–Frazier and colleagues
1st to report successful BTT with Thoratec Heartmate IP VAD (Implantable pneumatic)
Restored near normal hemodynamics.
What were its Limitations?

A

Devices dependent on large consoles for power and controller function
Patients confined to hospital until
transplantation despite being fully ambulatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

1991–Frazier at Texas Heart Institute

first to use what?

A

First to use an untethered vented electric LVAD for long term support
33 y/o patient
Battery operated Heartmate VE
500 days of support
Patient died of embolic cerebral vascular accident.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

1990–Kormos at University of Pittsburg

Developed a program to do what?

A

transfer VAD patients to a monitored outpatient setting until transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

1994–What was the first FDA approved implantable device for bridge to
transplant?

A

Heartmate LVAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Biological Barriers to VAD design (4)

A
  • Blood versus Foreign surface
  • Moving parts
  • Changes to patients anticoagulation and immune system over time in response to the mechanical pump
  • Pharmacologic modifications (Heparin, Coumadin, ASA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indications for VAD: Bridge to Transplant

A

Worsening hemodynamics despite high level
of IV inotropic support and/or vasodilator
therapy or refractor arrhythmias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Indications for VAD: Destination Therapy

A

Patients who are not transplant candidates.
Have an EF less than 25% and NYHA Class IV
symptoms despite optimal therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications for VAD two options?

A

Bridge to Transplant

Destination Therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Contraindications for VAD - tons

A
High surgical risk
Recent/evolving stroke
Neurological deficits impairing the ability to manage device
Coexisting terminal condition
Abdominal aortic aneurysm (greater than 5cm)
Active infection
Fixed pulmonary hypertension
Severe pulmonary dysfunction
Multisystem organ failure
Inability to tolerate anticoagulation
HIT
Psychiatric illness
Lack of social support
pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Design of a VAD must take into consideration? tons

A

Configured for their eventual application
(Shorter term vs partial assist vs long term support vs total support)
Different uses and device requirements impact design.
Anatomically compatible (Used over large variations in body mass, chest size/ shape, abdominal girth, etc.)
Structurally stable in a corrosive saline environment
Operate continuously w/o maintenance 4years.
Cannot fail under increased stress conditions
Reduce power requirements to save battery life
Must be efficient–reduce heat waste

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

2 different kinds of pumps for VAD

A
Positive displacements (Usually pneumatic)
Rotary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Flow and Pressure - Positive Displacement - how?

A

Change volume in the chamber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Flow and Pressure - Rotary - how?

A

Rotating Impeller

22
Q

Source of Energy Positive Displacement?

A

Air pressure/ Electricity

23
Q

Source of Energy - Rotary:

A

Electricity

24
Q

Is rotary of positive displacement smaller?

A

Rotary is smaller with a smaller cannula

25
Q

Prime Volume:

Positive Displacement:

A

Large Prime Volume

26
Q

Prime Volume - Rotary:

A

has a smaller Prime Volume than post displacement

27
Q

Flow Ranges for rotary and post displacement?

A

Both plagued with thrombosis with decreased flow and hemolysis with increased flow

28
Q

If Afterload changes what happens in- Post Displacement VAD pumps?

A

Unaffected by changes in afterload

29
Q

If Afterload increases what happens in Rotary VAD pumps?

A

Flow drops with increased SVR

30
Q

Comparison of Pump Types: Preload, Positive Displacement:

A

Passive filling, output follows venous return

31
Q

Comparison of Pump Types: Preload, Rotary:

A

Flow increases with increased VR, but no active suction applied

32
Q
Positive Displacement Pumps
Flow?
Mean BP?
HR rate?
Mean Filling Pressure?
A

Flow is about 5-10 liters per minute
Mean bp = 100-150 mmHg
Rate is <120 bpm
Mean filling pressure is appx 20mmHg

33
Q

Positive Displacement Pumps - how does flow work?

A

Propels fluid by changing the internal volume
of a pumping chamber.
Compression of a sac/membrane, etc.
Provides pulsatile flow
Requires 1 way valves to produce forward flow

34
Q

BIVAD–10% of LVADs will need a what?

A

RVAD

35
Q

BiVAD is common after what events?

and least used with what?

A

transplant failure, postpartum, Acute MI, Cardiomyopathy, Myocarditis.

Used least with idiopathic CM and Ischemic CM

36
Q

Thoratec PVAD/IVAD - provides what?

A

FDA Approved as a BTT since 1995
Provides support for the right, left or both
ventricles

37
Q

Preop risk factors for Right Heart Failure? (3)

A

Hemodynamics-
-Low CI with inc. RA pressure not necessarily an indicator of Rt. Heart failure.
May improve when LV is unloaded with LVAD
-Ability of RV to generate pressure
-Low pulse pressure with high CVP–indicator of BiVAD

38
Q

Indication of BiVAD from what two increased lab values?

A

Higher pre-op bilirubin

Higher pre -op creatinine

39
Q

Indicators for a BiVAD - 3

A

Emergent Implant
Intraop Bleeding
Greater transfusion requirements increases pulmonary vascular resistance and promotes the development of right heart failure.

40
Q

Post op what is common for BiVAD pts? and whats it related to?

A

Post op bleeding is common for BiVAD patients

Related to the severity of hepatic failure

41
Q
Thoratec PVAD/IVAD
Stroke volume pump chamber?
Beats ?
Flow is Lpm?
BSA >?
A

65 mL
Beats 40-110 bpm
Flow is 1.3-7.2 Lpm
BSA >0.73m2

42
Q

Thoratec PVAD/IVAD
Made of?
How many valves?
How does it pump?

A

Thoralon Polyurethane
2 mechanical valves
Alternate positive and negative air pressure by console/Portable driver

43
Q

Thoratec PVAD/IVAD

where is it placed in patients?

A

Placed in the anterior abdominal wall w/ cannulas crossing into the chest wall to connect the VAD to the heart and great vessels.
External location is suitable for use in smaller pts

Actuated by DDC for in hospital use & portable TLCII for ambulatory use TLCII approved in 2003

44
Q
Pump considerations for Implant: Thoratec PVAD/IVAD
Cannulation?
Temp?
CPG/XC?
LV Vent special indications?
Ultrafiltrate to keep HCT to what?
A

-Ideally use bicaval cannulation
-Normothermic
-w/o cardioplegia or XC
-LV Vented
-De-aired via LV Apex cannula before connecting to the VAD
-Ultrafiltrate to keep hematocrit greater than 30% (in case clotting factors are needed to
assist coagulation)

45
Q

Thoratec PVAD/IVAD
Anticoagulation w/what 1st & afterwards what?
INR?

A

Chronic Warfarin Anticoagulation
INR= 2.5-3.5
Starts with heparin–PTT 1.5x baseline until
GI function is stable and show low bleeding
risk (10-14 days)
Switch to warfarin and ASA

46
Q

PVAD–used as what?

some other random facts:
Mostly what gender? ischemic/idiopathic CM%?

A

BTT and Post Cardiotomy

1982-2005 : 2900 patients implanted 1,941 Heart Failure patients awaiting transplant on PVAD support
73% are males
Mean age: 48 years
BSA: 1.89m2
Weight: 75 kg
30% are ischemic CM
21% are idiopathic CM
47
Q

BIVADS - mean support? longest support?

A

–54%, LVADs-34%, RVAD–3%
Mean support: 51.8 days
Longest support: 3.3 years

48
Q

PVAD can be used in pediatrics due to being what?

A

paracorporeal

49
Q

Thoratec IVAD: Intracorporeal VAD (or Implantable VAD)
used when?
Approved for what?
BSA >?

A

Used when longer term support is anticipated
Approved in 2004 by the FDA as a BTT or BTR
BSA >1.3m2 b/c of intracorporeal position

50
Q

Thoratec IVAD: Intracorporeal VAD (or Implantable VAD) Difference from PVAD? (4)
body? wt? leads? mm?

A

Polished Titanium Body–makes it implantable
Reduced weight - 339gms vs. 417 gms
Narrower Percutaneous leads
9mm vs. 20mm